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target in OA. No simple test for BCP crystals is currently available
and their detection is difﬁcult due to their small size (nm) and the
complexity of the synovial ﬂuid (SF) samples in which they are
found. BCP crystals usually remain undetected under conven-
tional light microscopy. Unlike other high-resolution microscopic
and spectroscopic techniques, atomic force microscopy (AFM)
and Raman spectroscopy offer the advantage of portability, sim-
plicity and relatively inexpensive instrumentation. The aim of our
group is to develop novel analytical methods for the detection of
BCP microcrystals in SF samples based on AFM, Raman and
colorimetry.
Methods: Spiked samples were prepared by adding synthetic
BCP crystals into control (crystal-free) synovial ﬂuid in concen-
trations found in-vivo. Patient samples were aspirated from the
affected joints (mainly knees and shoulders) of patients with OA.
Control SF samples were either from the knee joints of patients
with early rheumatoid arthritis since these synovial ﬂuid samples
rarely contain BCP crystals or from sports injury knee patients
e.g. patients undergoing arthroscopy. AFM data was collected on
a AFM microscope (Molecular Imaging) on “tapping mode”. Ra-
man measurements were performed on a µ-Raman microscope
(785 nm excitation, Renishaw) on synthetic BCP crystals as well
as on spiked, OA and control SF samples. Colorimetric testing
was carried out by exposing SF samples to a number of crystal-
speciﬁc stains (e.g. alizarin, molybdate blue, o-cresolphthalein
complexone).
Results: AFM revealed the presence of small spheroids of
inorganic-like material of the size expected (nm) of BCP crystals
in samples from patients with severe OA. These features were
not observed in control SF samples. Raman spectral features
indicated that there are certain marker bands that are speciﬁc
to the BCP crystals (such as the phosphate stretching mode
at 960cm-1) which are absent in Raman spectra of SF contain-
ing calcium pyrophosphate dehydrate (CPPD) and monosodium
urate (MSU) crystals. Furthermore, CPPD and MSU also showed
speciﬁc signature modes at 1043 and 1068 cm-1 respectively.
Colorimetric testing indicated the presence of BCP in OA SF,
and could distinguish between BCP, CPPD, MSU and calcium
oxalate crystals.
Conclusions: All three approaches offer potential routes to-
wards a simple and objective diagnostic test for the detection of
BCP crystals in SF as a tool for improved diagnosis and char-
acterisation of osteoarthritis. Furthermore, we believe that these
techniques would be particularly suitable for point-of-care and
clinical applications.
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Purpose: Ultrasonography (US) has proved more sensitive than
clinical exploration for synovitis detection and has been used
successfully as therapeutic monitoring system in rheumatoid
arthritis in numerous published studies.
Chondroitin sulfate (CS) is an important constituent of most ver-
tebrate tissues. CS belongs to the group of glycosaminoglycans,
important structural constituents of cartilage extracellular matrix.
Controlled clinical trials evidence the symptomatic efﬁcacy and
safety of this drug in osteoarthritic patients.
Recently, CS has also proved to be effective in patients with
OA and synovitis (data from the Glucosamine and Chondroitin
Arthritis Intervention Trial -GAIT-). In this study, synovitis assess-
ment was conducted by means of clinical exploration. The aim
of the present study was to monitor by US the efﬁcacy of CS in
patients with OA and associated synovitis.
Methods: An observational study monitored with US for 6
months was conducted in 20 patients with OA and unilateral
knee synovitis, deﬁned according to OMERACT criteria 2004.
Among all patients, 9 presented grade 2 OA according to the
Kellgren & Lawrence (KL) scale and 11 presented KL grade 3.
All patients received treatment with 800 mg CS/day. Ultrasono-
graphic controls were conducted at baseline and after 1, 3 and 6
months by a single observer specialized in US. The contralateral
knee was used as control.
Results: In 8 out of the 9 patients with KL grade 2 and in 7
out of the 11 patients with KL grade 3 a progressive remission
of synovitis was observed, evident from the 3rd month onwards.
None of the contralateral knees developed synovitis. In one
patient with KL grade 2 there was no complete remission, with
persisting effusion, though less severe than at baseline. In 5
patients with KL grade 3, full doses of NSAIDs were necessary
for a period of 21 days.
Conclusions: US allows synovitis detection in osteoarthritic
patients and can be used as a therapeutic monitoring system of
the inﬂammatory activity in OA. CS at the dose of 800 mg/day
is an effective treatment to control synovitis in patients with OA,
conﬁrming previous data from the literature.
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Purpose: Purpose: To compare the 3D cartilage segmentation
performance of a quadrature transmit-receive extremity coil (USA
Instruments (Aurora OH)) and a phased array coil with quadrature
transmit, 8 channel receive extremity coil (InVivo Corporation
(Orlando FL)) using semi-automated analysis methods.
Methods: Measurements of cartilage volume, thickness, and
surface area were made using 10 (5 normal and 5 OA) subjects.
Eight subjects had unilateral knee acquisitions and 2 received a
bilateral scan, which provided a total of 12 knees for analysis.
The data were acquired as part of the Osteoarthritis Initiative
(OAI) pilot MR study. Each knee was imaged twice with each
coil, for a total of four acquisitions, on a 3 Tesla Siemens Trio
scanner using sagittal 3D DESS (0.365mm x 0.456mm, 0.7mm
slice thickness, TR 16.5msec, TE 4.7msec).
The MR images were analysed using a semi-automated cartilage
segmentation software that provided measurements of cartilage
volume, thickness, and surface area. We performed two analy-
ses. To test the hypothesis that a non-uniform receive (phased
array) coil could be used to segment cartilage, the “intra coil”
reproducibility was determined using duplicate scans from the
same coil. Scans for the intra coil reproducibility were read in a
paired manner whereby the reader was unblinded to patient for
